Smart. Safe. Samples
Smart4Diagnostics enables real-time digital monitoring and quality assurance of blood samples and changes medical diagnostics from a trust-based system into an evidence-based system.
About Our Project
Over 70% of all medical decisions are based on diagnostic results and are often obtained from blood samples. What most people don’t know is that blood samples are extremely sensitive to environmental conditions, e.g. on their way from the patient to the laboratory. Blood sample quality can deteriorate due to storage and transport conditions, to the point where the laboratory results are impacted on and the sample no longer represents the initial status of the patient.
Smart4Diagnostics (formerly DX-Labtrack) seeks to ensure that these storage and transport conditions are always reliably monitored. All relevant parameters are tracked directly via the blood sample tube with a smart sensor solution and then information is then compiled into a human-sample-digital-fingerprint.
Through the surveillance of blood samples in this way, we can change medical diagnostics from a trust-based to an evidence-based system, and medical doctors and patients can be sure that the analytical results are actually correct.
Smart4Diagnostics is based at UnternehmerTUM in Munich – Germany.
You can find out more on our website
Meet the Team
Dr. Yannick Timo Böge
Yannick Timo Böge is a molecular biologist and serves as analytical lead in the team. He has 10 years of experience in IVD (medical diagnostic devices) R&D including human sample management and logistics. He is a former Head of Laboratory in the medtech industry and his practical knowledge is a clear asset towards the technical success of our project.
Dr. Malte Dancker
Malte Dancker is a working physician who acts as our clinical lead. He has 3 years of experience in orthopedics, traumatology, health information management and evaluation of clinical processes. His insights are key to implementing new products into existing processes.
- Dr. Julia Flötotto
Julia Flötotto is an experienced software engineer and product lead with 10+ years of industry record. She has studied in Germany and France, and her recently obtained MBA in Entrepreneurship complements her expertise with a focus on business model design, design thinking and product management.
Dr. Hans Maria Heyn
Hans Maria Heyn is our team‘s business lead. He has 10 years experience in the field of Business Management, Innovation and Planning and is an is an expert in IVD and medical device regulatory affairs with a broad network of key opinion leaders.
OUR JOURNEY SINCE WILD CARD
- Pilot projects in 4 European countries, starting from September 2019;
- 6th start-up globally with full access to tech-specifications of Roche technology;
- €1 million investment by the High-Tech Gründerfonds (German public-private venture capital fund) pending final signatures;
- Finalists at Plug and Play Startup Creasphere Digital Health Accelerator Batch One in September 2018;
- WHO World Health Summit, Startup Finalist in October 2018;
- Finalists at Bill and Melinda Gates Foundation, Grand Challenges Annual Meeting in October 2018.
Our Wild Card Experience
Being part of Wild Card was an exceptional challenge and a gigantic step forward for us personally and for the project.
Encouraged by the coaches from CIMIT to get out and challenge our idea through interviewing a wide range of potential customers and partners, we were able to sharpen our understanding of the market and the problem that we are aiming to address.